PGMN3 Pharmacy Network: 1,657 Stores and Clinic Farma

Pague Menos (PGMN3) FRE business description is the map behind the digital and covenant posts: second-largest Brazilian pharmacy chain by store count, with a health-services overlay.

This page summarizes a business-model analysis from the 2025 FRE (figures through mid-2025 where disclosed). apicvm returns the filings.

The research question

> Describe history, business model, strategy, advantages, and market position.

Network and M&A

Fact Figure
Founded 1981 (Fortaleza, CE)
IPO September 2020
Extrafarma acquisition (2022) ~391 stores; ~R$ 267 million annual incremental EBITDA synergies (estimate)
Store count (30 Jun 2025) 1,657
Distribution centers 9

Offer and services

  • ~17k SKUs; >900 exclusive/private-label products (~6.3% of 1H25 sales)
  • Specialty medicines unit (AME): >600 products (~1.3% of 1H25 sales)
  • Loyalty / CRM: >57 million registered customers; ~92% of sales identified
  • Clinic Farma in 1,155 units — company states Clinic Farma customers spend ~ the average customer
  • Digital share of gross revenue: 18.2% in 1H25; Click & Collect in 100% of stores

Market position (IQVIA 2Q25)

Geography Share
Brazil 6.6%
Northeast 20.6%
North 16.0%

Brazil pharmacy market cited ~R$ 221 billion (2Q25). Same-store sales +17.6% and adjusted EBITDA margin 5.2% in 1H25.

Prior PGMN3 digital post focused on omnichannel %. This page is the full franchise footprint — stores, Extrafarma, Clinic Farma, and regional share.

Replicate with apicvm

export APICVM_KEY='apicvm_...'
export APICVM_URL='https://apicvm.dev'

curl -H "Authorization: Bearer $APICVM_KEY" \
  "$APICVM_URL/v1/companies/resolve?query=PGMN3&by=ticker"

curl -H "Authorization: Bearer $APICVM_KEY" \
  "$APICVM_URL/v1/documents?ticker=PGMN3&type=FRE&year=2025&name=Hist"

curl -X POST -H "Authorization: Bearer $APICVM_KEY" \
  -H "Content-Type: application/json" \
  -d '{"callback_url":"https://your-server/callback","document":{"id":"<id>"}}' \
  "$APICVM_URL/v1/document-text-extractions"

Methodology note

Findings above come from a completed Hold analysis of the company's public 2025 FRE. This is a research illustration, not investment, legal, or tax advice. Verify numbers against the original filing before trading, modeling, or publishing reports.

Limitations

  • apicvm returns filings and extracted text — it does not classify risks or compute coverage ratios.
  • Figures are as of the FRE filing date; later ITRs or facts relevantes can update them.
  • Corpus coverage depends on ingestion lag.

Next steps

Ready to integrate?

Get an API key and start querying Brazilian CVM filings programmatically.